is semaglutide under patent The upcoming expiry of the in India in mid-March 2026 expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Obesity Drugs Set To Take

GBB-EEC (Gamma-Butyrobetaine HCL) is known asa 'Pro-Carnitine' moleculeas our body actually converts GBB into L-Carnitine in the body, up to 300% more potent than L-Carnitine alone

Drug Interaction Semaglutide slows down gastric emptying and may therefore affect the absorption rate of orally administered drugs taken concomitantly

The initial rush also led to overstocking of the drugs, with the market reporting excess inventory of nearly 100 crore by June

Since 2020, the number of prescriptions made for these drugs has more than tripled (Jain, 2023)

At some point we will see that plateau as more consumers try it. At Medica, every client employer group covers GLP-1 medications for FDA-approved diabetes indications